Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Movers
  • News

Why Toy Maker Hasbro’s Shares Are Shooting Higher Today

By Shivani Kumaresan
April 24, 8:26 AM
Hasbro reports a 24.4% year-on-year sales decline in first-quarter FY24, totaling $757.30 million. However, the company beats analyst estimates, with adjusted EPS of $0.61 outperforming the consensus of $0.27. Hasbro's operating margin expands significantly, reaching 15.3%.

HAS

Read More
2 minute read
  • General
  • Markets
  • News

Boeing Faces Potential Criminal Prosecution As Crash Victims’ Families Demand Justice: ‘Throw Out The DPA’

By Benzinga Neuro
April 24, 8:18 AM
The victims' families are pushing for an independent monitor to ensure Boeing's adherence to the agreement, a stipulation not included in Boeing's original deal.

BA

Read More
1 minute read
  • Biotech
  • General
  • News

Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection In Cancer Validated By Cas9-Directed Nanopore Sequencing

By Benzinga Newsdesk
April 24, 8:14 AM
Bionano Genomics, Inc. (NASDAQ:BNGO), today announced the results of an implementation study conducted by researchers at University Medical Center Groningen that compared optical genome mapping (OGM) to traditional

BNGO

Read More
1 minute read
  • Dividends
  • Earnings
  • Equities
  • General
  • Guidance
  • Movers
  • News

Hilton Stock Is Jumping Post Q1 Results – Here’s Why

By Shivani Kumaresan
April 24, 8:14 AM
Hilton Worldwide surpasses analyst estimates with first-quarter FY24 sales reaching $2.573 billion, marking a 12.2% year-on-year increase. Franchise and licensing fees revenue rose 12.4%, while the company's owned and leased hotels revenue grew by 2.8%.

HLT

Read More
2 minute read
  • Analyst Color
  • Cryptocurrency
  • General
  • Markets
  • News

‘Took Guts To Own Bitcoin:’ SkyBridge’s Anthony Scaramucci Says It Would Need ‘Brains’ To Reap BTC Rally

By Benzinga Neuro
April 24, 8:09 AM
Anthony Scaramucci, the founder of SkyBridge Capital, recently expressed his views on Bitcoin (CRYPTO: BTC), suggesting that owning the cryptocurrency now requires more intellect than courage.

BTC

Read More
1 minute read
  • Biotech
  • General
  • News

CalciMedica Announces Last Patient Enrolled In Phase 2b CARPO Trial Of Auxora In Acute Pancreatitis; Full Target Enrollment Of 216 Patients Achieved

By Benzinga Newsdesk
April 24, 8:08 AM
Full target enrollment of 216 patients achieved Topline data from CARPO expected in 2Q 2024 LA JOLLA, Calif., April 24, 2024 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica") (NASDAQ:CALC), a clinical-stage

CALC

Read More
2 minute read
  • Biotech
  • General
  • News

Pasithea Therapeutics Announces The First Cohort Has Completed The Initial Dosing In Its Phase 1 Trial Evaluating PAS-004 In RAS, NF1 And RAF Mutated Cancers

By Benzinga Newsdesk
April 24, 8:05 AM
Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor for the treatment of neurofibromatosis type

KTTA

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • General
  • Markets
  • News
  • Tech

Move Over Nvidia: Experts Bullish On Intel’s AI Chip, Predict Surge In These Three Global Stocks

By Benzinga Neuro
April 24, 7:51 AM
Charlie Chan and his team at Morgan Stanley forecast that the total Gaudi shipment volume could hit 300-400k units in 2025, generating $2-3bn revenue for Intel.

ALCPF

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • General
  • Markets
  • News
  • Tech

Move Over Nvidia: Experts Bullish On Intel’s AI Chip, Predicts Surge In These Three Global Stocks

By Benzinga Neuro
April 24, 7:51 AM
Charlie Chan and his team at Morgan Stanley forecast that the total Gaudi shipment volume could hit 300-400k units in 2025, generating $2-3bn revenue for Intel.

ALCPF

Read More
1 minute read
  • Earnings
  • Equities
  • General
  • Movers
  • News

Why Is Lithia Motors Stock Sliding Today?

By Shivani Kumaresan
April 24, 7:40 AM
Lithia Motors reported first-quarter FY24 sales growth of 23% year-on-year to $8.56 billion, beating the analyst consensus estimate of $8.54 billion. Adjusted EPS of $6.11 missed the analyst consensus of $7.89.

LAD

Posts pagination

Previous 1 … 172 173 174 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service